Lazcluze Tablet, Film Coated
Product Images NDC 57894-240

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lazcluze (NDC 57894-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lazcluze 01)

Chemical Structure (Lazcluze 01)
Chemical structure of lazertinib, the active ingredient in LAZCLUZE tablets. The structure includes multiple nitrogen-containing rings and functional groups, depicting the molecular composition of lazertinib monohydrate with a methanesulfonic acid component.*
FDA Label Image

Figure 1 (Lazcluze 02)

Figure 1 (Lazcluze 02)
A Kaplan-Meier survival curve chart showing the proportion of patients surviving without progression over 33 months. It compares LAZCLUZE plus amivantamab versus Osimertinib, with LAZCLUZE plus amivantamab demonstrating a higher survival proportion. The x-axis is labeled in months, and the y-axis shows the proportion surviving without progression, accompanied by a table of numbers at risk over time for each treatment group.*
FDA Label Image

Principal Display Panel (240 mg Tablet Bottle Carton)

Principal Display Panel (240 mg Tablet Bottle Carton)
Packaging label for Lazcluze 240 mg film-coated tablets containing lazertinib. The label indicates oral tablet dosage form, with storage instructions and dosage warnings. Manufactured for Janssen Biotech, Inc., the carton includes barcodes, tamper area markings, and mentions a package count of 30 tablets. Product origin is Belgium.*
FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Carton)

Principal Display Panel (80 mg Tablet Bottle Carton)
Packaging label for Lazcluze (lazertinib) tablets, 80 mg strength. The film-coated oral tablets are supplied in a package containing 60 tablets. The label includes the Janssen logo and identifies Janssen Biotech, Inc. as the manufacturer. It also notes storage instructions and that the product is child-resistant. The label features barcodes and tamper-evident areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.